Literature DB >> 24053637

The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same.

Miki N Hew1, Dedan Opondo, Ernesto R Cordeiro, Karlijn A M I van Donselaar-van der Pant, Frederike J Bemelman, Mirza M Idu, Jean J M C H de la Rosette, M Pilar Laguna.   

Abstract

OBJECTIVES: To determine short-term differences in renal function evolution between patients with renal cell carcinoma (RCC) submitted to radical nephrectomy (RN) and living kidney donors matched for age and gender. To assess the role of co-morbidity as a risk factor for developing an estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73 m(2) . PATIENTS AND METHODS: In this retrospective study patients undergoing Radical Nefrectomy (RN) between January 2000 and February 2011 for suspicion of localised RCC were matched by age and gender to living kidney donors. Renal function was compared between the groups using the Modification in Diet and Renal Disease (MDRD) equation at 1 year after RN. Charlson co-morbidity score, incidence of hypertension, diabetes and cardiovascular disease were compared and assessed as predictors for developing an eGFR of <60 mL/min/1.73 m(2) .
RESULTS: In all, 196 patients were included, 98 in each group. The mean age was respectively 60.6 (RCC group) and 59.1 years (donors). The 1-year postoperative mean eGFR (available in 89 patients with RCC and 87 donors) was similar, at a mean (sd) of 56.7 (16.4) mL/min/1.73 m(2) in patients with RCC and 56.2 (9.8) mL/min/1.73 m(2) in donors (P = 0.83). In patients with RCC the incidence and severity of co-morbidities was significantly higher. A preoperative eGFR of 60-89 mL/min/1.73 m(2) was the only independent risk factor for developing a postoperative eGFR of <60 mL/min/1.73 m(2) (odds ratio 4.4, confidence interval 2.1-9.5, P < 0.001, 95% confidence interval).
CONCLUSIONS: In our cohorts with advanced age the 1-year follow-up eGFR was similar in both groups. Despite increased co-morbidity in the RCC group there was no increased decline in renal function. Only reduced preoperative eGFR could be identified as risk factor for developing a postoperative eGFR of <60 mL/min/1.73 m(2) .
© 2013 The Authors. BJU International © 2013 BJU International.

Entities:  

Keywords:  co-morbidity; living donor; nephrectomy; renal cell carcinoma; renal function

Mesh:

Year:  2013        PMID: 24053637     DOI: 10.1111/bju.12345

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  4 in total

1.  Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer.

Authors:  Daniel Vergho; Maximilian Burger; Moritz Schrammel; Sabine Brookman-May; Michael Gierth; Bernd Hoschke; Kai Lopau; Christian Gilfrich; Hubertus Riedmiller; Ingmar Wolff; Matthias May
Journal:  World J Urol       Date:  2014-10-25       Impact factor: 4.226

Review 2.  Risk for cancer in living kidney donors and recipients.

Authors:  Min Wang; Huai Zhang; Dan Zhou; Yong-Chao Qiao; Yan-Hong Pan; Yan-Chao Wang; Hai-Lu Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-22       Impact factor: 4.553

3.  Influence of CT-based depth correction of renal scintigraphy in evaluation of living kidney donors on side selection and postoperative renal function: is it necessary to know the relative renal function?

Authors:  Sarah Weinberger; Carola Klarholz-Pevere; Lutz Liefeldt; Michael Baeder; Nico Steckhan; Frank Friedersdorff
Journal:  World J Urol       Date:  2018-03-22       Impact factor: 4.226

4.  Predictive model of 1-year postoperative renal function after living donor nephrectomy.

Authors:  Thibaut Benoit; Xavier Game; Mathieu Roumiguie; Federico Sallusto; Nicolas Doumerc; Jean Baptiste Beauval; Pascal Rischmann; Nassim Kamar; Michel Soulie; Bernard Malavaud
Journal:  Int Urol Nephrol       Date:  2017-03-01       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.